AI assistant
Proto Labs Inc — Director's Dealing 2013
Jul 10, 2013
32102_dirs_2013-07-10_18c5ed3b-8607-4798-8c08-e7927d8be994.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Proto Labs Inc (PRLB)
CIK: 0001443669
Period of Report: 2013-07-08
Reporting Person: Tumelty John B. (Managing Dir.-Proto Labs, Ltd.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-07-08 | Common Stock | M | 10500 | $7.86 | Acquired | 10500 | Direct |
| 2013-07-08 | Common Stock | S | 8009 | $64.4692 | Disposed | 2491 | Direct |
| 2013-07-08 | Common Stock | S | 2491 | $65.415 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-07-08 | Employee Stock Option (right to buy) | $7.86 | M | 10500 | Disposed | 2020-01-21 | Common Stock (10500) | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2013.
F2: Reflects the weighted average price of 8,009 shares of common stock of Proto Labs, Inc. sold by the reporting person in multiple transactions on July 8, 2013 with sale prices ranging from $64.15 to $65.14 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Reflects the weighted average price of 2,491 shares of common stock of Proto Labs, Inc. sold by the reporting person in multiple transactions on July 8, 2013 with sale prices ranging from $65.154 to $65.85 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: On 5/23/13, the Issuer's Board of Directors approved a change to the vesting terms of the stock option granted to the reporting person on 12/21/10. The stock option is amended to vest on a monthly basis in 2013 and will then vest 20% of the shares annually on each of 12/21/14 and 12/21/15.